Paris, February 13, 2026 – Jeantet advises Vivo Capital, a leading global investment firm focused on healthcare sector and life sciences, on its acquisition of the Dutscher Group, European leader in the distribution of consumables and equipment for R&D laboratories.

The deal will mark Vivo Capital’s first buyout investment in Europe and underscores the firm’s continued expansion as a global healthcare investor, building on its long-standing leadership across North America and Asia.

This transaction, that should be finalized in the course of the first semester 2026, will enable Dutscher, which had been owned by LBO France since 2020, to strengthen its European presence, accelerate both organic and external growth, and leverage Vivo Capital’s global expertise and network to expand its product range, develop new business opportunities, and optimize supplier relationships.

Alongside the law firm Sidley Austin LLP, the Jeantet team advising on this transaction was led by Vincent Netter, M&A partner, and included Alexandre Naudeau, counsel, and Alice Sevestre and Nicolas Giliberti, associates, on M&A and corporate matters, Benjamin May, partner, and Pauline Choupot, associate, on IP and IT matters, Caroline André-Hesse, partner, together with Anissa Froz and Elsa Layani, associates, on employment law, Alexae Fournier-de Faÿ, partner, and Julien Angot, associate, on financial matters and Adrien Fourmon, partner, and Ananova Lohmann, associate, on public law aspects.

Download the press release